This company recently went public with an IPO on Thursday, September 11th 2025. They issued 19,000,000 shares at $15.00 per share. We will continue to update data for LBRX as it becomes available. LB Pharmaceuticals (LBRX) Competitors $15.16 +0.26 (+1.74%) As of 09:03 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock LBRX vs. ATNFW, LBPSW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, BCTXW, and CALAShould you be buying LB Pharmaceuticals stock or one of its competitors? The main competitors of LB Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. LB Pharmaceuticals vs. Its Competitors 180 Life Sciences 4D pharma Ainos Alvotech ARAVIVE Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences LB Pharmaceuticals (NASDAQ:LBRX) and 180 Life Sciences (NASDAQ:ATNFW) are both pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations. Which has higher earnings and valuation, LBRX or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLB PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to LBRX or ATNFW? In the previous week, LB Pharmaceuticals had 5 more articles in the media than 180 Life Sciences. MarketBeat recorded 5 mentions for LB Pharmaceuticals and 0 mentions for 180 Life Sciences. LB Pharmaceuticals' average media sentiment score of 0.72 beat 180 Life Sciences' score of 0.00 indicating that LB Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment LB Pharmaceuticals Positive 180 Life Sciences Neutral Is LBRX or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets LB PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryLB Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get LB Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LBRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LBRX vs. The Competition Export to ExcelMetricLB Pharmaceuticals IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$340.19M$2.42B$2.54B$10.50BDividend YieldN/A13.77%2.49%4.58%P/E RatioN/A25.9626.4726.62Price / SalesN/A11,253.86218.8991.77Price / CashN/A19.9851.2461.85Price / BookN/A3.7233.216.45Net IncomeN/A-$372.80M$14.12M$271.57M7 Day PerformanceN/A0.44%0.62%2.55%1 Month PerformanceN/A2.18%3.73%7.22%1 Year PerformanceN/A13.38%70.48%29.60% LB Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LBRXLB PharmaceuticalsN/A$15.16+1.7%N/AN/A$340.19MN/A0.0016News CoverageAnalyst UpgradeInsider TradeATNFW180 Life SciencesN/A$0.09+17.0%N/A+871.2%$0.00N/A0.007Gap UpLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAIMDWAinosN/A$0.16+3.2%N/AN/A$0.00$110.87K0.0040Positive NewsGap DownALVOWAlvotechN/A$1.09+5.5%N/A-42.9%$0.00$560.10M0.004Gap DownARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/A+12.3%$0.00N/A0.0015BFRIWBiofronteraN/A$0.11flatN/A+359.5%$0.00$39.19M0.0070BTMDWbioteN/A$0.01-6.0%N/A-99.4%$0.00$199.07M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.03-2.3%N/A-88.2%$0.00N/A0.008Gap DownCALACalithera BiosciencesN/AN/AN/A-99.2%$0.00N/A0.0060 Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Ainos Alternatives Alvotech Alternatives ARAVIVE Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Calithera Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LBRX) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredRecession Risk: 90% — Are Your Savings Ready?Moody's latest report shows one-third of U.S. economic activity is already in recession or at high risk.Lear Capital | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LB Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share LB Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LBRX Stock Alerts